A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

MJ Penarrubia, J Odriozola, C Gonzalez… - Annals of …, 2003 - Springer
Abstract Interferon-alpha (IFN-α) is a therapy of unquestionable efficacy in chronic myeloid
leukemia (CML) patients. The best dose of IFN-α in the treatment of CML still remains …
被引用次数：14 相关文章

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

MJ Penarrubia, J Odriozola, C Gonzalez… - Annals of …, 2003 - elibrary.ru
Interferon-alpha (IFN-α) is a therapy of unquestionable efficacy in chronic myeloid leukemia
(CML) patients. The best dose of IFN-α in the treatment of CML still remains controversial …

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses.

MJ Peñarrubia, J Odriozola, C González… - Annals of …, 2003 - europepmc.org
Interferon-alpha (IFN-alpha) is a therapy of unquestionable efficacy in chronic myeloid
leukemia (CML) patients. The best dose of IFN-alpha in the treatment of CML still remains …

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

MJ Pearrubia, J Odriozola, C Gonzlez, I Massagu… - Annals of …, 2003 - infona.pl
Interferon-alpha (IFN-) is a therapy of unquestionable efficacy in chronic myeloid leukemia
(CML) patients. The best dose of IFN-in the treatment of CML still remains controversial. Our …

[引用][C] A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

MJ PENARRUBIA, J ODRIOZOLA… - … of hematology (Print …, 2003 - pascal-francis.inist.fr
A randomized study of intermediate as compared with high doses of interferon-alpha for chronic
myeloid leukemia: no differences in cytogenetic responses CNRS Inist Pascal-Francis CNRS …

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses.

MJ Peñarrubia, J Odriozola, C González… - Annals of …, 2003 - search.ebscohost.com
Abstract Interferon-alpha (IFN-α) is a therapy of unquestionable efficacy in chronic myeloid
leukemia (CML) patients. The best dose of IFN-α in the treatment of CML still remains …

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

MJ Peñarrubia, J Odriozola… - Annals of …, 2003 - pubmed.ncbi.nlm.nih.gov
Interferon-alpha (IFN-alpha) is a therapy of unquestionable efficacy in chronic myeloid
leukemia (CML) patients. The best dose of IFN-alpha in the treatment of CML still remains …

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

MJ Peñarrubia, J Odriozola, C González… - Annals of …, 2003 - search.proquest.com
Abstract Interferon-alpha (IFN-α) is a therapy of unquestionable efficacy in chronic myeloid
leukemia (CML) patients. The best dose of IFN-α in the treatment of CML still remains …

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses.

MJ Peñarrubia, J Odriozola, C González… - Annals of …, 2003 - search.ebscohost.com
Abstract Interferon-alpha (IFN-α) is a therapy of unquestionable efficacy in chronic myeloid
leukemia (CML) patients. The best dose of IFN-α in the treatment of CML still remains …

[引用][C] A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

MJ Peñarrubia, J Odriozola, C González… - Annals of …, 2003 - Springer